Jaejin An to United States
This is a "connection" page, showing publications Jaejin An has written about United States.
Connection Strength
1.248
-
Cardiovascular and Kidney Events Associated with Visit-to-Visit Blood Pressure Variability among Young Adults with Hypertension. Am J Hypertens. 2026 Aug 01; 39(8):988-996.
Score: 0.135
-
Validation of electronic health record-based International Society on Thrombosis and Haemostasis bleeding algorithms in a US health system. Res Pract Thromb Haemost. 2026 May; 10(4):106616.
Score: 0.133
-
Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. J Gen Intern Med. 2026 05; 41(7):1881-1891.
Score: 0.129
-
Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System. J Am Coll Cardiol. 2026 Mar 24; 87(11):1327-1339.
Score: 0.128
-
Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
Score: 0.125
-
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
Score: 0.122
-
Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems. Clin J Am Soc Nephrol. 2022 10; 17(10):1457-1466.
Score: 0.103
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.091
-
Association between different types of comorbidity and disease burden in patients with diabetes. J Diabetes. 2019 Jan; 11(1):65-74.
Score: 0.077
-
Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol. 2018 06; 25(3):257-265.
Score: 0.075
-
Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
Score: 0.066
-
Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2536100.
Score: 0.032
-
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
Score: 0.032